Naive CD8+ T-cells pre-mark their mitochondrial genes with histone H2A.Z, directed by GABPα and tonic IL-7 signaling, to activate within hours of meeting a threat. This preparation weakens with age but can be restored, and the same approach strengthens anti-tumor CAR-T therapy
Naive CD8+ T-cells pre-mark their mitochondrial genes with histone H2A.Z, directed by GABPα and tonic IL-7 signaling, to activate within hours of meeting a threat. This preparation weakens with age but can be restored, and the same approach strengthens anti-tumor CAR-T therapy
A mouse study by a team at the Chinese Academy of Sciences was published on September 18 in Science Advances. A year earlier, the same laboratory had shown that H2A.Z primes memory CD8+ T-cells for rapid response; the present work finds the same mechanism in cells that have never encountered a pathogen.
A naive CD8+ T-cell, a killer cell, conserves resources while waiting for an enemy, but the moment it meets the precise threat it is tuned to recognize, it has only hours to mount a full response: proliferate, begin producing effector proteins, and rewire its metabolism. How the cell holds this readiness on standby had remained unclear for years.
The answer lay in DNA packaging. H2A.Z is a variant histone, one of the protein spools around which the cell winds its DNA to fit two meters of genome into a microscopic nucleus. Where H2A.Z sits, the packaging is looser and the gene is easier to activate. In mice with H2A.Z knocked out specifically in T-cells, both naive and effector populations were visibly reduced, and the remaining cells were less effective at controlling a model bacterial infection and melanoma tumor growth. The cause was specific: without H2A.Z, mitochondrial respiratory chain genes activated far more weakly upon stimulation, and adding pure ATP, the cell's energy currency, to the culture partially restored the capacity to activate. Energy deficit itself is what keeps these cells passive.
What directs H2A.Z to these genes was determined by mass spectrometry: the top hit was GABPα, a protein known since the 1990s under the name nuclear respiratory factor 2 as one of the principal activators of mitochondrial genes. 89% of the DNA sites that GABPα occupies in naive T-cells overlap with H2A.Z sites, and directly targeting GABPα to a gene causes H2A.Z to be deposited at that exact location.
The system is set in motion by a third player, interleukin-7 (IL-7), a signaling protein that stromal cells of the bone marrow and thymus secrete throughout the T-cell's life. Without the IL-7 receptor, H2A.Z loads less efficiently onto energy genes, and the marking accumulates gradually, from an immature cell in the thymus to a mature naive cell in the periphery, as though the cell passes through an extended training program.
This training ages along with IL-7. In middle-aged mice (40 weeks versus 8), levels of IL-7 and its receptor fall, H2A.Z occupancy on energy genes drops with them, and the cells respond sluggishly to infection and tumor. Two approaches correct this: injection of IL-7 restores both H2A.Z loading and function, while overexpression of H2A.Z restores function even without restoring IL-7.
The same lever worked in CAR-T cells, T lymphocytes equipped with an engineered receptor that recognizes tumor. Within the tumor microenvironment, H2A.Z is already diminished, and the closer a cell is to exhaustion (a state in which it stops attacking the tumor despite remaining formally alive), the less H2A.Z it contains. By forcing CAR-T cells to overexpress H2A.Z, the authors obtained cells that controlled tumors more effectively in two mouse models, displayed fewer markers of exhaustion, and produced more interferon-γ, a signaling protein that drives the anti-tumor attack.
In the discussion, the authors capture their finding in one sentence:
We call this trained immunity of T-cells
Long before meeting an enemy, the cell tunes its metabolism for the battle ahead, and this readiness is inscribed directly in its chromatin marks. It waits for just one signal: that it is still needed.